RxDoctor Payments Data

Tiffany Danford

Adult Health · West Grove, PANPI 1700664323

Payments from drug & device makers

$1,454in general payments, 2019–2025

Across 35 payments — averaging $41.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bridgebio Pharma, Inc.$252
  • Amgen$201
  • Medtronic$148
  • Alnylam Pharmaceuticals Inc.$143
  • AstraZeneca$140
  • Boehringer Ingelheim$139
  • plus $430 from 5 others

What the payments were for

  • Food & beverage$1,454100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,454 in reported general payments places this provider in the 70th percentile of 899 adult health providers in Pennsylvania.

See all adult health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$8,942
Medicare patients
250
Services billed
300

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban47$54,709
EntrestoSacubitril/Valsartan16$26,036
Metoprolol Succinate123$1,929
Valsartan37$1,187
Ezetimibe31$728
Rosuvastatin Calcium58$693
Isosorbide Mononitrate ErIsosorbide Mononitrate26$642
Atorvastatin Calcium46$616
Amlodipine Besylate56$465
Potassium Chloride14$423
Furosemide63$325
Pravastatin Sodium27$299
Diltiazem 24hr Er (Cd)Diltiazem Hcl20$291
ClopidogrelClopidogrel Bisulfate15$191
Losartan Potassium23$131

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$139$54,70947 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 899 adult health providers in Pennsylvania.

Other adult health in West Grove

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →